Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +12

Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

William R. Jarnagin, Yuman Fong, Ronald P. DeMatteo et al. · Annals of Surgery · 2001 · 1.4K citations

Medicine, Oncology, Surgery +17

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

Shahid A. Khan, Brian R Davidson, Robert Goldin et al. · Gut · 2012 · 793 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda et al. · Journal of Clinical Oncology · 2013 · 633 citations

Medicine, Oncology, Pharmacology +13